Company intelligence / Profile preview

Respiratory Motion

Watertown/Boston area, Massachusetts, United Statespmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Development stage: Commercial

Overview

The ExSpiron system by Respiratory Motion provides continuous non-invasive monitoring of minute ventilation and breathing frequency. It has been validated in over 30 peer-reviewed publications from leading institutions and demonstrated to improve early detection of postoperative respiratory depression and failure. The technology enables safer patient triage and discharge decisions while reducing complications and healthcare costs.

Therapeutic areas: Pulmonology
Modalities: DeviceNon-pharmacological therapy
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Respiratory Motion.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Respiratory Motion.

Explore the full profile